Login
$SUND
$0.20 -$0.04 (16.32%) Close

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q1 FY2027
As of Jun 30, 2026
Q4 FY2026
As of Mar 31, 2026
Q3 FY2026
As of Dec 31, 2025
Q2 FY2026
As of Sep 30, 2025
Q1 FY2026
As of Jun 30, 2025
Q4 FY2025
As of Mar 31, 2025
Q3 FY2025
As of Dec 31, 2024
Q2 FY2025
As of Sep 30, 2024
Q1 FY2025
As of Jun 30, 2024
Q4 FY2024
As of Mar 31, 2024
Q3 FY2024
As of Dec 31, 2023
Q2 FY2024
As of Sep 30, 2023
Q1 FY2024
As of Jun 30, 2023
Q4 FY2023
As of Mar 31, 2023
Q3 FY2023
As of Dec 31, 2022
Q2 FY2023
As of Sep 30, 2022
Q1 FY2023
As of Jun 30, 2022
Q4 FY2022
As of Mar 31, 2022
Q3 FY2022
As of Dec 31, 2021
Q2 FY2022
As of Sep 30, 2021
ASSETS
Current Assets
Cash and cash equivalents
Prepaid expenses and other assets
Total Current Assets
Total Assets
LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current Liabilities
Accounts payable
Accrued expenses
Current portion of notes payable
Nonrelated Party
Related Party
Stock repurchase payable
Total Current Liabilities
Long-Term Liabilities
Accrued expenses
Notes payable, net of current portion
Nonrelated Party
Related Party
Total notes payable, net of current portion
Total Long-Term Liabilities
Total Liabilities
Stockholders’ Deficit
Common stock, authorized 500,000,000 shares, par value $0.001; 43,063,441 shares issued and outstanding as of June 30, 2026; and March 31, 2026
Additional paid-in capital
Accumulated deficit
Total Stockholders’ Deficit
Total Liabilities and Stockholders’ Deficit

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support